These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 15712148)
1. The influence of chemotherapy on bone marrow in patients with chronic lymphocytic leukaemia. Lemancewicz D; Dziecioł J; Kłoczko J; Piszcz J Folia Morphol (Warsz); 2004 Nov; 63(4):485-9. PubMed ID: 15712148 [TBL] [Abstract][Full Text] [Related]
2. Use of image analysis and immunostaining of bone marrow trephine biopsy specimens to quantify residual disease in patients with B-cell chronic lymphocytic leukemia. Gala JL; Guiot Y; Delannoy A; Scheiff JM; Philippe M; Martiat P Mod Pathol; 1999 Apr; 12(4):391-9. PubMed ID: 10229504 [TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptors expression in bone marrow trephine biopsy of chronic lymphocytic leukaemia patients treated with purine analogues. Piszcz JA; Lemancewicz D; Kloczko J; Dzieciol J; Rusak M; Dabrowska M Exp Oncol; 2007 Sep; 29(3):221-5. PubMed ID: 18004250 [TBL] [Abstract][Full Text] [Related]
5. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update. Molica S; De Rossi G; Luciani M; Levato D Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755 [TBL] [Abstract][Full Text] [Related]
6. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia. Ural AU; Kubar A; Avcu F; Tastan HB; Safali M; Nevruz O; Cetin T Clin Exp Dermatol; 2007 Mar; 32(2):151-4. PubMed ID: 17244344 [TBL] [Abstract][Full Text] [Related]
7. Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia. Pfitzner T; Reiser M; Barth S; Borchmann P; Schulz H; Schinköthe T; Oberhäuser F; Wessels J; Tur M; Diehl V; Engert A Ann Hematol; 2002 May; 81(5):258-66. PubMed ID: 12029535 [TBL] [Abstract][Full Text] [Related]
8. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. Bouzar AB; Boxus M; Defoiche J; Berchem G; Macallan D; Pettengell R; Willis F; Burny A; Lagneaux L; Bron D; Chatelain B; Chatelain C; Willems L Br J Haematol; 2009 Jan; 144(1):41-52. PubMed ID: 19006566 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70). Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520 [TBL] [Abstract][Full Text] [Related]
10. Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy. Molica S; Vacca A; Tucc L; Ribatti D Haematologica; 2005 May; 90(5):698-700. PubMed ID: 15921392 [TBL] [Abstract][Full Text] [Related]
11. Assessment of expression of selected Bcl-2 family proteins in lymphoid infiltration in patients with B-cell chronic lymphocytic leukaemia treated with nucleoside analogues. Lemancewicz D; Dziecioł J; Piszcz J; Lebelt A; Mazgajska-Barczyk K; Klim B; Kłoczko J Folia Histochem Cytobiol; 2008; 46(3):361-6. PubMed ID: 19056541 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the sensitivity of flow cytometry and bone marrow biopsy in the detection of minimal residual disease in chronic lymphocytic leukemia. Maloum K; Charlotte F; Divine M; Cazin B; Lesty C; Merle-Béral H; Haematologica; 2006 Jun; 91(6):860-1. PubMed ID: 16769593 [TBL] [Abstract][Full Text] [Related]
13. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia. Lam CC; Ma ES; Kwong YL Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456 [TBL] [Abstract][Full Text] [Related]
14. Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication. Bosch F; Ferrer A; Villamor N; González M; Briones J; González-Barca E; Abella E; Gardella S; Escoda L; Pérez-Ceballos E; Asensi A; Sayas MJ; Font L; Altés A; Muntañola A; Bertazzoni P; Rozman M; Aymerich M; Giné E; Montserrat E Clin Cancer Res; 2008 Jan; 14(1):155-61. PubMed ID: 18172266 [TBL] [Abstract][Full Text] [Related]
15. Metabolic response patterns of nucleotides in B-cell chronic lymphocytic leukaemias to cladribine, fludarabine and deoxycoformycin. Wilson PK; Mulligan SP; Christopherson RI Leuk Res; 2004 Jul; 28(7):725-31. PubMed ID: 15158094 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow biopsy in chronic lymphocytic leukemia. Rozman C; Montserrat E Nouv Rev Fr Hematol (1978); 1988; 30(5-6):369-71. PubMed ID: 3065734 [TBL] [Abstract][Full Text] [Related]
18. Advances in the diagnosis and treatment of chronic lymphocytic leukemia. Abbott BL Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221 [TBL] [Abstract][Full Text] [Related]
19. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation. Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956 [TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of cytologic and histomorphologic changes in bone marrow in the treatment of patients with chronic lymphocytic leukemia]. Belić A; Stajnic S Med Pregl; 1991; 44(5-6):220-4. PubMed ID: 1808481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]